RHUMBLINE ADVISERS - ACCELERATE DIAGNOSTICS INC ownership

ACCELERATE DIAGNOSTICS INC's ticker is AXDX and the CUSIP is 00430H102. A total of 118 filers reported holding ACCELERATE DIAGNOSTICS INC in Q4 2020. The put-call ratio across all filers is 18.58 and the average weighting 0.1%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of ACCELERATE DIAGNOSTICS INC
ValueSharesWeighting
Q2 2023$1,328
-97.4%
1,640
-95.4%
0.00%
Q1 2022$51,000
-73.2%
35,763
-1.8%
0.00%
Q4 2021$190,000
-11.2%
36,435
-0.5%
0.00%
Q3 2021$214,000
-25.2%
36,636
+3.2%
0.00%
Q2 2021$286,000
-7.4%
35,488
-4.6%
0.00%
Q1 2021$309,000
+4.7%
37,198
-4.5%
0.00%
Q4 2020$295,000
-24.6%
38,968
+6.3%
0.00%
-100.0%
Q3 2020$391,000
-38.4%
36,658
-12.5%
0.00%0.0%
Q2 2020$635,000
+105.5%
41,913
+12.9%
0.00%0.0%
Q1 2020$309,000
-50.5%
37,117
+0.6%
0.00%0.0%
Q4 2019$624,000
-8.2%
36,908
+0.7%
0.00%0.0%
Q3 2019$680,000
-18.0%
36,645
+1.2%
0.00%
-50.0%
Q2 2019$829,000
+13.4%
36,223
+4.2%
0.00%
+100.0%
Q1 2019$731,000
+80.9%
34,754
-1.1%
0.00%0.0%
Q4 2018$404,000
-27.2%
35,148
+45.3%
0.00%0.0%
Q3 2018$555,000
-3.8%
24,191
-6.5%
0.00%0.0%
Q2 2018$577,000
-0.3%
25,866
+2.0%
0.00%0.0%
Q1 2018$579,000
-15.2%
25,356
-2.8%
0.00%0.0%
Q4 2017$683,000
-2.3%
26,086
-16.2%
0.00%
-50.0%
Q3 2017$699,000
-17.2%
31,138
+0.9%
0.00%0.0%
Q2 2017$844,000
+24.3%
30,863
+9.9%
0.00%0.0%
Q1 2017$679,000
+20.2%
28,076
+3.1%
0.00%
+100.0%
Q4 2016$565,000
-14.9%
27,223
+11.8%
0.00%
-50.0%
Q3 2016$664,000
+93.6%
24,352
+2.3%
0.00%
+100.0%
Q2 2016$343,000
+3.0%
23,815
+2.7%
0.00%0.0%
Q1 2016$333,000
-26.7%
23,191
+9.8%
0.00%0.0%
Q4 2015$454,000
+44.1%
21,116
+8.3%
0.00%0.0%
Q3 2015$315,000
-35.1%
19,491
+3.7%
0.00%
-50.0%
Q2 2015$485,000
+1.9%
18,791
-11.1%
0.00%
+100.0%
Q1 2015$476,000
+38.8%
21,146
+18.3%
0.00%0.0%
Q4 2014$343,000
-10.9%
17,871
-0.3%
0.00%0.0%
Q3 2014$385,000
-18.3%
17,921
-1.0%
0.00%0.0%
Q2 2014$471,00018,1010.00%
Other shareholders
ACCELERATE DIAGNOSTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Birchview Capital, LP 4,387,590$46,772,00015.62%
ORACLE INVESTMENT MANAGEMENT INC 4,091,749$43,618,0005.75%
GRIFFIN ASSET MANAGEMENT, INC. 1,439,613$15,346,0002.36%
Selkirk Management LLC 348,805$3,718,0001.18%
Chicago Capital, LLC 1,966,891$20,967,0001.08%
Trellus Management Company, LLC 46,834$499,0000.51%
Cannell & Co. 1,118,439$11,923,0000.44%
OAKTOP CAPITAL MANAGEMENT II, L.P. 155,000$1,652,0000.36%
Belpointe Asset Management LLC 419,406$3,982,0000.27%
TCI Wealth Advisors, Inc. 55,586$593,0000.23%
View complete list of ACCELERATE DIAGNOSTICS INC shareholders